These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations. Chen C; Wicha SG; Nordgren R; Simonsson USH AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471 [TBL] [Abstract][Full Text] [Related]
3. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?]. Ozseven AG; Sesli Çetin E; Ozseven L Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653 [TBL] [Abstract][Full Text] [Related]
4. Assessment and modelling of antibacterial combination regimens. Rao GG; Li J; Garonzik SM; Nation RL; Forrest A Clin Microbiol Infect; 2018 Jul; 24(7):689-696. PubMed ID: 29269090 [TBL] [Abstract][Full Text] [Related]
12. Experimental designs for detecting synergy and antagonism between two drugs in a pre-clinical study. Sperrin M; Thygesen H; Su TL; Harbron C; Whitehead A Pharm Stat; 2015; 14(3):216-25. PubMed ID: 25810342 [TBL] [Abstract][Full Text] [Related]
13. A method for testing for synergy with any number of agents. Berenbaum MC J Infect Dis; 1978 Feb; 137(2):122-30. PubMed ID: 627734 [TBL] [Abstract][Full Text] [Related]
14. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance? Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model. Zhuang L; Sy SK; Xia H; Singh RP; Mulder MB; Liu C; Derendorf H Int J Antimicrob Agents; 2015 Feb; 45(2):151-60. PubMed ID: 25465523 [TBL] [Abstract][Full Text] [Related]
16. Application of ED-optimality to screening experiments for analgesic compounds in an experimental model of neuropathic pain. Taneja A; Nyberg J; de Lange EC; Danhof M; Della Pasqua O J Pharmacokinet Pharmacodyn; 2012 Dec; 39(6):673-81. PubMed ID: 23197247 [TBL] [Abstract][Full Text] [Related]
17. An R-shiny application to calculate optimal designs for single substance and interaction trials in dose response experiments. Holland-Letz T; Kopp-Schneider A Toxicol Lett; 2021 Feb; 337():18-27. PubMed ID: 33232777 [TBL] [Abstract][Full Text] [Related]
18. New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents. Sato N; Suzuki H; Hayashi H; Shibasaki S; Sugano T; Maebashi K; Kurosawa T; Shiomi M; Ogata H Jpn J Antibiot; 2008 Oct; 61(5):314-38. PubMed ID: 19260351 [TBL] [Abstract][Full Text] [Related]
19. Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods. Sy CL; Huang TS; Chen CS; Chen YS; Tsai HC; Wann SR; Wu KS; Chen JK; Lee SS; Liu YC J Clin Microbiol; 2016 Mar; 54(3):565-8. PubMed ID: 26677253 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus. Wicha SG; Kees MG; Kuss J; Kloft C Pharm Res; 2015 Jul; 32(7):2410-8. PubMed ID: 25630818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]